Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: skinowski who wrote (6624)	4/7/2009 6:22:58 PM
From: TimF	Read Replies (1) \| Respond to of 42652

Having a good choice of treatment options is not a problem, it's the solution, or at least part of it. One of the points raised in the article is that treating disease or condition A, B, C, and D in the same person often shouldn't be the same as applying the normal treatment for A,B,C, and D to that person. Drug interactions can cause problems. The combination of diseases or disorders can add other complications besides the normal complications of each disease or those of drug interactions. One of the points of the article is that we need to work more to develop effective treatment regimes for people with multiple conditions. That's not an argument against "a good choice of treatment options" or an "anti-capitalist" or even "anti-pharma" point.